Mario Gabelli Takeda Pharmaceutical CO LTD Transaction History

Gamco Investors, Inc. Et Al

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$14.59 - $19.5 $926,246 - $1.24 Million	-63,485 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$13.02 - $20.31 $2,343 - $3,655	180 Added 0.28%	63,485 $964,000
Q4 2019 Feb 14, 2020	SELL	$16.88 - $20.83 $26,282 - $32,432	-1,557 Reduced 2.4%	63,305 $1.25 Million
Q3 2019 Nov 01, 2019	BUY	$16.15 - $17.99 $83,253 - $92,738	5,155 Added 8.63%	64,862 $1.12 Million
Q2 2019 Aug 02, 2019	BUY	$16.58 - $20.49 $2,735 - $3,380	165 Added 0.28%	59,707 $1.06 Million
Q1 2019 May 02, 2019	BUY	$16.7 - $21.52 $994,351 - $1.28 Million	59,542 New	59,542 $1.21 Million

338

68.6M

1.72M

178K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $44.6B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Gamco Investors, Inc. Et Al, based on Form 13F filings with the SEC.

Stay updated on Gamco Investors, Inc. Et Al and Mario Gabelli with notifications on news.